BROSHY ERAN
SEC CIK 1256230 · EDGAR
BoughtSold
Most active insiders at CERT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Feehery William F | CEO, Dir | $200.0K | — |
| 2 | Bedi Arjun | Dir | — | — |
| 3 | Resnick Jon Matthew | CEO, Dir | — | — |
| 4 | McKemey Adrian | Pres, Drug Dev. Solutions | — | — |
| 5 | Reynders John V W | CFO, Dir | — | — |
| 6 | Corcoran Daniel | SVP, GC | — | — |
| 7 | Anhalt Rona | CHRO | — | — |
| 8 | Aspbury Robert | Pres, PREDICTIVE TECH | — | — |
| 9 | Gallagher John E | CFO | — | — |
| 10 | Killefer Nancy | Dir | — | — |
| 15 | BROSHY ERAN | Dir, COB | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-15 16:28 | 2026-05-14 | CERT | Certara, Inc. | BROSHY ERAN | Dir, COB | M - OptEx | $0.00 | +15.8K | 50.7K | +45% | $0 |
| DM | 2025-12-01 | 2025-11-26 | TBPH | Theravance Biopharma, Inc. | BROSHY ERAN | Dir | S - Sale | $20.00 | -29.5K | 60.2K | -33% | -$590.0K |
| DMA | 2025-11-14 | 2025-11-11 | TBPH | Theravance Biopharma, Inc. | BROSHY ERAN | Dir | S - Sale | $17.98 | -45.0K | 60.2K | -43% | -$809.2K |
| DM | 2025-11-13 | 2025-11-11 | TBPH | Theravance Biopharma, Inc. | BROSHY ERAN | Dir | S - Sale | $18.11 | -59.0K | 61.7K | -49% | -$1.07M |
| D | 2025-05-22 | 2025-05-21 | CERT | Certara, Inc. | BROSHY ERAN | Dir, COB | M - OptEx | $0.00 | +11.9K | 35.0K | +52% | $0 |
| D | 2025-05-21 | 2025-05-19 | TBPH | Theravance Biopharma, Inc. | BROSHY ERAN | Dir | A - Grant | $0.00 | +10.6K | 91.2K | +13% | $0 |
| D | 2024-05-23 | 2024-05-21 | CERT | Certara, Inc. | BROSHY ERAN | Dir | M - OptEx | $0.00 | +8,663 | 23.0K | +60% | $0 |
| D | 2024-05-10 | 2024-05-08 | TBPH | Theravance Biopharma, Inc. | BROSHY ERAN | Dir | A - Grant | $0.00 | +10.5K | 80.6K | +15% | $0 |
| M | 2023-08-23 | 2023-08-21+ | CERT | Certara, Inc. | BROSHY ERAN | Dir | P - Purchase | $15.81 | +5,000 | 14.4K | +53% | +$79.1K |
| D | 2023-05-25 | 2023-05-23 | CERT | Certara, Inc. | BROSHY ERAN | Dir | M - OptEx | $0.00 | +9,360 | 9,360 | New | $0 |
| D | 2023-05-04 | 2023-05-02 | TBPH | Theravance Biopharma, Inc. | BROSHY ERAN | Dir | A - Grant | $0.00 | +9,132 | 70.0K | +15% | $0 |
| D | 2022-04-28 | 2022-04-26 | TBPH | Theravance Biopharma, Inc. | BROSHY ERAN | Dir | A - Grant | $0.00 | +9,852 | 60.9K | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations